Role of a Pediatric Cardiologist in the COVID-19 Pandemic

Talha Niaz1, Kyle Hope2, Michael Fremed3

  • 1Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.

Pediatric Cardiology
|October 5, 2020
PubMed

Insights

Children with COVID-19 can develop multisystem inflammatory syndrome (MIS-C), presenting distinct gastrointestinal and shock-like symptoms. Cardiovascular involvement, including myocardial dysfunction and coronary artery issues, is a significant concern in these pediatric cases.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) impacts all ages, with varying severity.
  • While younger individuals generally experience milder COVID-19, a severe multisystem inflammatory syndrome in children (MIS-C) has emerged.
  • MIS-C shares features with Kawasaki disease but presents unique gastrointestinal and shock-like symptoms.

Purpose of the Study:

  • To review current literature on cardiovascular involvement in pediatric COVID-19 and MIS-C.
  • To summarize the understanding of cardiac manifestations in children affected by COVID-19 or MIS-C.
  • To define the role of pediatric cardiologists in managing these complex cases.

Main Methods:

  • Literature review of studies on pediatric COVID-19 and MIS-C.
  • Synthesis of findings regarding cardiovascular complications.
  • Analysis of clinical presentations and management strategies.

Main Results:

  • Children with MIS-C frequently exhibit severe gastrointestinal symptoms and shock.
  • Significant cardiovascular involvement is observed, including myocardial dysfunction, valvulitis, and coronary artery aneurysms.
  • Distinct differences exist between MIS-C and typical Kawasaki disease presentations.

Conclusions:

  • Cardiovascular complications are a critical aspect of MIS-C in children.
  • Pediatric cardiologists play a vital role in the diagnosis and management of these patients.
  • Further research is needed to fully understand and treat cardiac sequelae of COVID-19 in children.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
376
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
226
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
330
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
130